The Double Root Rotation, Double Switch Operation and Ross-Konno Procedure are the novel surgical procedures achieved at the national centre
Photo credit: National University Heart Centre, Singapore (NUHCS)
Four-year-old Nur Faathimah Assyifa’ (middle) who underwent the Double Switch Operation, holding a 3D model of her heart, with (from left to right):
Singapore — From life-changing complex surgeries to heartwarming stories of resilience and recovery, the paediatric cardiac team at the National University Heart Centre, Singapore (NUHCS) has seen them all.
Congenital heart disease (CHD) is the most common birth defect globally, affecting numerous lives every year. More than half of patients with structural CHD will require cardiac surgery in their lifetime, with close to 70 per cent needing intervention within the first six months of life.
The multidisciplinary team at NUHCS performs about 100 to 150 interventions per year. This includes catheter-based and surgical procedures, reflecting NUHCS’s role as a beacon of hope and a treatment centre of choice for complex CHD.
In 2022 and 2023, the paediatric cardiac surgery team at NUHCS, led by Associate Professor Laszlo Kiraly, successfully performed three different highly complex and novel congenital heart procedures: Double Root Rotation, Double Switch Operation, and the Ross-Konno Procedure.
Associate Professor Kiraly, Head and Senior Consultant, Department of Cardiac, Thoracic and Vascular Surgery, NUHCS, said, “These procedures not only represent significant advances in treating complex congenital heart defects but also offer crucial opportunities for survival and improved quality of life.”
A comprehensive programme for congenital heart disease
These complex surgeries often require extensive pre-surgery planning and the NUHCS team has been integrating the latest innovations – including 3D modelling and printing, mixed reality and augmented visualisation – in preparation for these operations. The team is also exploring the use of artificial intelligence and robotics, nanotechnology, bioprinting and bioengineering in the future.
The treatment of complex CHD cases is part of NUHCS’s comprehensive programme for CHD, which includes a dedicated team of specialists and allied health professionals providing round-the-clock service for emergency and elective CHD treatment. These include comprehensive continuity-of-care (pre-operation, post-operation and follow-up), an Extra Corporeal Membrane Oxygenation (ECMO)/Extracorporeal Life Support (ELS) programme and treatment options for all ages from neonatal complex repairs to adult congenital cardiac care.
Through personalised care and advanced surgical interventions, NUHCS continues to lead in the treatment of paediatric cardiac conditions, striving for better outcomes and brighter futures for children.
To download the PDF version of the media release, click here.